Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

NCT00332280 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

67

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy. Stopped at first interim evaluation point

Conditions

Gastrointestinal Cancer
Prostate Cancer
Genital Neoplasms, Female

Interventions

DRUG: AMT2003

Sponsor

Auron Healthcare GmbH